ARCHIVES

Levamisole/5-FU Could Save $226 Mil. If Fully Adopted, NCI Economist Says

This article is from The Cancer Letter archive.

Vol. 16 No. 16 | April 20, 1990

Download PDF Visit The Full Archive

Related Articles

Talactoferrin Second-Line Therapy Increases Survival In Stage IIIB/IV

October 28, 2011

Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival

April 27, 2012

Program Announcements For Tobacco Research

January 21, 1983

DeVita Suggest “Overlay Consortium” as Outreach Mechanism for Southern California, Other Areas

September 28, 1984

NIEHS Awards $5M Grant for New Health Sciences Center to Robert Wood Johnson Medical School

January 20, 1989

Satraplatin With Prednisone Reduces Risk Of Disease Progression By 33% In Study

March 30, 2007